Discussion: The
K103 N/S mutation predominated, reflecting that efavirenz and nevirapine continue to be widely used in many developing countries.
Discussion: The frequency of both
K103 N/S and
M18 V/I resistance mutations was three-fold higher in our newly diagnosed population compared to provincial data.